Table 4 Comparison of Endostar with PBDC versus PBDC alone by different stratifications
Item | Wang JW 2005[11] | Yang L 2005[12] | ||||
|---|---|---|---|---|---|---|
Group 1 N (%) | Group 2 N (%) | P-value | Group 1 N (%) | Group 2 N (%) | P-value | |
Sex | ||||||
Male | 74 (32.3) | 19 (16.2) | 0.001 | - | - | - |
Female | 40 (43.0) | 13 (27.7) | 0.08 | - | - | - |
Histology | ||||||
SCC | 49 (38.0) | 10 (18.2) | 0.009 | 11 (47.8) | 3 (30) | 0.476 |
LAC | 54 (32.7) | 17 (17.3) | 0.007 | 6 (22.2) | 5 (21.7) | 1.000 |
Others | 11 (39.3) | 5 (45.5) | 0.72 | |||
TNM stage | ||||||
IIIA | 17 (33.3) | 5 (16.7) | 0.11 | 10 (52.6) | 3 (23.1) | 0.147 |
IIIB | 29 (33.7) | 10 (22.2) | 0.17 | |||
IV | 68 (36.8) | 17 (19.1) | 0.003 | 9 (25.7) | 5 (25) | 1.000 |
Treatment history | ||||||
No | 92 (40.0) | 28 (23.9) | 0.003 | 10 (37) | 4 (19) | 0.214 |
Yes | 22 (23.9) | 4 (8.5) | 0.034 | 10 (37) | 4 (33.3) | 1.000 |